Biblio

Export 135 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is T  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
S. Tholen, Schmaderer, C., Chmielewski, S., Förstl, H., Heemann, U., Baumann, M., Steubl, D., and Grimmer, T., “Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?”, J Alzheimers Dis, vol. 50, no. 3, pp. 791-6, 2016.
V. Thirunavu, McCullough, A., Su, Y., Flores, S., Dincer, A., Morris, J. C., Cruchaga, C., Benzinger, T. L. S., and Gordon, B. A., “Higher Body Mass Index Is Associated with Lower Cortical Amyloid-β Burden in Cognitively Normal Individuals in Late-Life.”, J Alzheimers Dis, vol. 69, no. 3, pp. 817-827, 2019.
S. Thibeau, G McFall, P., Camicioli, R., and Dixon, R. A., “Alzheimer's Disease Biomarkers Interactively Influence Physical Activity, Mobility, and Cognition Associations in a Non-Demented Aging Population.”, J Alzheimers Dis, vol. 60, no. 1, pp. 69-86, 2017.
C. Theunis, Adolfsson, O., Crespo-Biel, N., Piorkowska, K., Pihlgren, M., Hickman, D. T., Gafner, V., Borghgraef, P., Devijver, H., Pfeifer, A., Van Leuven, F., and Muhs, A., “Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope.”, J Alzheimers Dis, vol. 56, no. 2, pp. 585-599, 2017.
C. Themistocleous, Ficek, B., Webster, K., Ouden, D. - Bden, Hillis, A. E., and Tsapkini, K., “Automatic Subtyping of Individuals with Primary Progressive Aphasia.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1185-1194, 2021.
R. Thangavel, Bhagavan, S. M., Ramaswamy, S. Beladakere, Surpur, S., Govindarajan, R., Kempuraj, D., Zaheer, S., Raikwar, S., Ahmed, M. E., Selvakumar, G. Pushpavath, Iyer, S. S., and Zaheer, A., “Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 61, no. 2, pp. 553-560, 2018.
C. E. Teunissen, Chiu, M. - J., Yang, C. - C., Yang, S. - Y., Scheltens, P., Zetterberg, H., and Blennow, K., “Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1857-1863, 2018.
K. A. Tetzloff, Graff-Radford, J., Martin, P. R., Tosakulwong, N., Machulda, M. M., Duffy, J. R., Clark, H. M., Senjem, M. L., Schwarz, C. G., Spychalla, A. J., Drubach, D. A., Jack, C. R., Lowe, V. J., Josephs, K. A., and Whitwell, J. L., “Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1713-1724, 2018.
N. Terry, Masliah, A., Overk, C., and Masliah, E., “Remembering Robert D. Terry at a Time of Change in the World of Alzheimer's Disease.”, J Alzheimers Dis, vol. 70, no. 3, pp. 621-628, 2019.
N. Shu Ning Teoh, Gyanwali, B., Lai, M. K. P., Chai, Y. Ling, Chong, J. R., Chong, E. Jun Yi, Chen, C., Tan, C. Seng, and Hilal, S., “Association of Interleukin-6 and Interleukin-8 with Cognitive Decline in an Asian Memory Clinic Population.”, J Alzheimers Dis, vol. 92, no. 2, pp. 445-455, 2023.
O. Tene, Hallevi, H., Korczyn, A. D., Shopin, L., Molad, J., Kirschbaum, C., Bornstein, N. M., Shenhar-Tsarfaty, S., Kliper, E., Auriel, E., Usher, S., Stalder, T., and Ben Assayag, E., “The Price of Stress: High Bedtime Salivary Cortisol Levels Are Associated with Brain Atrophy and Cognitive Decline in Stroke Survivors. Results from the TABASCO Prospective Cohort Study.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1365-1375, 2018.
G. Tell-Marti, Puig-Butille, J. Anton, Potrony, M., Plana, E., Badenas, C., Antonell, A., Sánchez-Valle, R., Molinuevo, J. L., Lleo, A., Alcolea, D., Fortea, J., Fernández-Santiago, R., Clarimón, J., Lladó, A., and Puig, S., “A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1065-1074, 2017.
C. M. Teixeira, Pallas-Bazarra, N., Bolós, M., Terreros-Roncal, J., Avila, J., and Llorens-Martín, M., “Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S497-S505, 2018.
S. J. Teipel, Metzger, C. D., Brosseron, F., Buerger, K., Brueggen, K., Catak, C., Diesing, D., Dobisch, L., Fliebach, K., Franke, C., Heneka, M. T., Kilimann, I., Kofler, B., Menne, F., Peters, O., Polcher, A., Priller, J., Schneider, A., Spottke, A., Spruth, E. J., Thelen, M., Thyrian, R. J., Wagner, M., Düzel, E., Jessen, F., and Dyrba, M., “Multicenter Resting State Functional Connectivity in Prodromal and Dementia Stages of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 3, pp. 801-813, 2018.
S. Teipel and Grothe, M. J., “Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1443-51, 2016.
S. J. Teipel, Keller, F., Thyrian, J. R., Strohmaier, U., Altiner, A., Hoffmann, W., and Kilimann, I., “Hippocampus and Basal Forebrain Volumetry for Dementia and Mild Cognitive Impairment Diagnosis: Could It Be Useful in Primary Care?”, J Alzheimers Dis, vol. 55, no. 4, pp. 1379-1394, 2017.
S. J. Teipel, Dyrba, M., Ballarini, T., Brosseron, F., Bruno, D., Buerger, K., Cosma, N. - C., Dechent, P., Dobisch, L., Düzel, E., Ewers, M., Fliessbach, K., Haynes, J. D., Janowitz, D., Kilimann, I., Laske, C., Maier, F., Metzger, C. D., Munk, M. H., Peters, O., Pomara, N., Preis, L., Priller, J., Rámirez, A., Roy, N., Scheffler, K., Schneider, A., Schott, B. H., Spottke, A., Spruth, E. J., Wagner, M., Wiltfang, J., Jessen, F., and Heneka, M. T., “Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum.”, J Alzheimers Dis, vol. 85, no. 3, pp. 1267-1282, 2022.
B. Teichmann, Gkioka, M., Kruse, A., and Tsolaki, M., “Informal Caregivers' Attitude Toward Dementia: The Impact of Dementia Knowledge, Confidence in Dementia Care, and the Behavioral and Psychological Symptoms of the Person with Dementia. A Cross-Sectional Study.”, J Alzheimers Dis, vol. 88, no. 3, pp. 971-984, 2022.
A. F. Teich, Sakurai, M., Patel, M., Holman, C., Saeed, F., Fiorito, J., and Arancio, O., “PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 295-302, 2016.
S. Tebrügge, Winkler, A., Gerards, D., Weimar, C., Moebus, S., Jöckel, K. - H., Erbel, R., and Jokisch, M., “Olfactory Function is Associated with Cognitive Performance: Results of the Heinz Nixdorf Recall Study.”, J Alzheimers Dis, vol. 63, no. 1, pp. 319-329, 2018.
T. Tarumi, Rossetti, H., Thomas, B. P., Harris, T., Tseng, B. Y., Turner, M., Wang, C., German, Z., Martin-Cook, K., Stowe, A. M., Womack, K. B., Mathews, D., Kerwin, D. R., Hynan, L., Diaz-Arrastia, R., Lu, H., C Cullum, M., and Zhang, R., “Exercise Training in Amnestic Mild Cognitive Impairment: A One-Year Randomized Controlled Trial.”, J Alzheimers Dis, vol. 71, no. 2, pp. 421-433, 2019.
W. Tarraf, Rodríguez, C. J., Daviglus, M. L., Lamar, M., Schneiderman, N., Gallo, L., Talavera, G. A., Kaplan, R. C., Fornage, M., Conceicao, A., and González, H. M., “Blood Pressure and Hispanic/Latino Cognitive Function: Hispanic Community Health Study/Study of Latinos Results.”, J Alzheimers Dis, vol. 59, no. 1, pp. 31-42, 2017.
P. N. Tariot, Braeckman, R., and Oh, C., “Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil.”, J Alzheimers Dis, vol. 90, no. 1, pp. 161-172, 2022.
L. Tariciotti, Casadei, M., Honig, L. S., Teich, A. F., Ii, G. M. McKhann, Tosto, G., and Mayeux, R., “Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1417-1425, 2018.
F. E. Taragano, Allegri, R. F., Heisecke, S. L., Martelli, M. I., Feldman, M. L., Sánchez, V., García, V. A., Tufro, G., Castro, D. M., Leguizamón, P. Perez, Guelar, V., Ruotolo, E., Zegarra, C., and Dillon, C., “Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment Group.”, J Alzheimers Dis, vol. 62, no. 1, pp. 227-238, 2018.

Pages